ABMDR is a non-profit organisation that seeks to facilitate both health care and research.
All research applications go through an operational and ethical review to ensure protection of the welfare, rights, dignity and safety of research participants and researchers. Once a research project has been approved, cost recovery fees are charged for all expenses associated with the conduct of the research. There are no fees to submit a research application to the ABMDR.
|Low or negligible risk (LNR) applications||Full application|
|Research projects considered as LNR research, as defined in the National Statement on Ethical Conduct in Human Research – Risk and Benefit, require the following application documents:||Research projects that involve more than LNR will go through the full review process. The following application documents must be submitted:
ABMDR also welcomes research applications from transplant and donor centre members of the World Marrow Donor Association (WMDA). Research applications from these international centres require the following documents in English:
- Letter of request outlining the planned research and what is required from the ABMDR and its donors
- Copy of the research protocol or a summary of the research proposal
- Donor information and consent
- Evidence of ethical approval from local committees
REVIEW AND APPROVAL
Review of research applications looks to protect ABMDR’s reputation and minimise potential risks for claims of negligence made against individual researchers and the ABMDR.
Researchers are responsible for managing all approved research projects, independent of the level of risks, regarding amendments, reporting requirements and record keeping.
ABMDR research evaluation is based on the requirements of:
- National Statement on Ethical Conduct in Human Research
- Privacy Act 1988
- Guidelines under Section 95 of the Privacy Act 1988
- Research Governance and Ethics Advice
All research should be conducted in accordance with these standards.
The ethical assessment is conducted by the Australian Red Cross Lifeblood Ethics Committee. Initial ethics approval is for a period of three years, subject on meeting the reporting requirements.
To learn the steps to follow once the application is approved, check the Monitoring page
Have any questions, please contact ABMDR Research.